Radiopharm Theranostics Limited ADR (RADX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
| 06-2025 | 12-2024 | 06-2024 | |
| Cash Flows From Operating Activities | |||
| Net Income | -24,831 | N/A | -31,445 |
| Depreciation Amortization | 1,681 | N/A | 2,050 |
| Other Working Capital | -3,853 | N/A | 4,626 |
| Other Operating Activity | 3,271 | -14,474 | 9,701 |
| Operating Cash Flow | $-23,732 | $-14,474 | $-15,068 |
| Cash Flows From Investing Activities | |||
| Purchase Sale Intangibles | N/A | 1,953 | N/A |
| Other Investing Activity | 1,147 | 1,953 | 0 |
| Investing Cash Flow | $1,147 | $1,953 | $0 |
| Cash Flows From Financing Activities | |||
| Debt Repayment | N/A | -1,238 | N/A |
| Common Stock Issued | N/A | 29,867 | N/A |
| Other Financing Activity | 29,421 | -4,778 | 19,593 |
| Financing Cash Flow | $29,421 | $23,851 | $19,593 |
| Exchange Rate Effect | -10 | 307 | -16 |
| Beginning Cash Position | 12,029 | 12,102 | 7,672 |
| End Cash Position | 18,856 | 23,739 | 12,182 |
| Net Cash Flow | $6,827 | $11,637 | $4,509 |
| Free Cash Flow | |||
| Operating Cash Flow | -23,732 | -14,474 | -15,068 |
| Free Cash Flow | -23,732 | -14,474 | -15,068 |